Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
406 studies found for:    metabolic syndrome AND syndrome X AND insulin resistance AND diabetes
Show Display Options
Rank Status Study
1 Recruiting Incidence of Type 2 Diabetes in the di@Bet.es Study
Conditions: Diabetes Mellitus, Type 2;   Metabolic Syndrome X
Intervention:
2 Completed Surgical Removal of Visceral Fat Tissue (Omentectomy) Associated to Bariatric Surgery: Effects on Insulin Sensitivity
Conditions: Insulin Resistance;   Obesity;   Metabolic Syndrome X
Interventions: Procedure: Roux-en-Y Gastric Bypass plus total omentectomy;   Procedure: Roux-en-Y Gastric Bypass
3 Unknown  Frequency of Metabolic Syndrome in Down Syndrome Patients
Conditions: Metabolic Syndrome X;   Down Syndrome
Intervention:
4 Completed Efficacy of a Prebiotic Galactooligosaccharide to Reduce Metabolic Syndrome Risk Factors in Overweight Adults
Condition: Metabolic Syndrome X
Interventions: Dietary Supplement: Bimuno;   Dietary Supplement: Maltodextrin
5 Suspended Efficacy of Topiramate for Weight Loss in Subjects With Metabolic Syndrome
Conditions: Metabolic Syndrome X;   Diabetes Mellitus, Type 2
Intervention: Drug: topiramate
6 Completed Effects of Macronutrients on Hepatic Lipids, Plasma Triglycerides, and Insulin Sensitivity
Conditions: Metabolic Syndrome X;   Liver Diseases
Intervention: Other: diet intervention
7 Recruiting Culturally-adapted Diabetes Prevention Lifestyle Intervention for Latinos (E-LITE Latinos)
Conditions: Prediabetic State;   Metabolic Syndrome X;   Insulin Resistance
Interventions: Behavioral: Vida Sana;   Other: Usual Care Only
8 Completed Ziprasidone for Improving Insulin Sensitivity in People With Schizophrenia Who Are at Risk for Diabetes
Conditions: Schizophrenia;   Metabolic Syndrome X;   Insulin Resistance
Interventions: Drug: Ziprasidone;   Drug: Standard atypical antipsychotic drug
9 Completed
Has Results
Effects of PPAR Ligands on Ectopic Fat Accumulation and Inflammation
Conditions: Metabolic Syndrome X;   Prediabetic State
Interventions: Drug: Fenofibrate 145mg PO QD;   Drug: Pioglitazone 45 mg PO QD
10 Active, not recruiting
Has Results
Oral Contraceptives in the Metabolic Syndrome
Conditions: Metabolic Syndrome X;   Insulin Resistance;   Obesity;   Cardiovascular Diseases
Intervention: Drug: Ortho Tri Cyclen
11 Completed Effect Of Rosiglitazone On Carotid Intima Media Thickness In Patients With Insulin Resistance Syndrome And/Or Type 2 Diabetes
Condition: Diabetes Mellitus, Type 2
Intervention: Drug: Rosiglitazone
12 Completed Effects of Chromium Supplementation on Parameters of the Metabolic Syndrome in Patients With Type 2 Diabetes Mellitus
Condition: Diabetes Mellitus, Type 2
Intervention: Drug: Baker’s yeast (Bio Chromium)
13 Completed Sitagliptin Prophylaxis for Glucocorticoid-Induced Impairment of Glucose Metabolism in Males With the Metabolic Syndrome
Conditions: Diabetes Mellitus;   Steroid Diabetes;   Glucocorticoid-induced Diabetes;   Beta-cell Function
Interventions: Drug: Sitagliptin 100 mg;   Drug: Prednisolone 30 mg;   Drug: Sitagliptin-placebo;   Drug: Prednisolone-placebo
14 Unknown  The Roles of Cytokines in the Mechanism of Insulin Resistance and Energy Balance
Conditions: Metabolic Syndrome X;   Cachexia;   Insulin Resistance
Intervention:
15 Completed Mechanism of Fatty Acid-Induced Impairment of Glucose-Stimulated Insulin Secretion
Conditions: Insulin Resistance Syndrome X;   Pancreatic Beta Cell Function
Intervention: Drug: N-acetylcysteine, intralipid, heparin
16 Recruiting Metformin in the Diastolic Dysfunction of Metabolic Syndrome
Conditions: Metabolic Syndrome X;   Diastolic Dysfunction;   Insulin Resistance
Interventions: Behavioral: Lifestyle Counseling;   Drug: Metformin
17 Completed Metabolic Syndrome and Insulin Resistance at Allina
Condition: Metabolic Syndrome
Intervention: Dietary Supplement: vitamin D3 (cholecalciferol)
18 Completed Magnesium and Metabolic Syndrome: A Dose-response Meta-analysis
Conditions: Metabolic Syndrome X;   Insulin Resistance Syndrome X;   Metabolic Cardiovascular Syndrome;   Dysmetabolic Syndrome X
Intervention:
19 Unknown  Pharmacogenetic Profiling of Antipsychotics-Induced X-Syndrome and Diabetes (PAXD)
Conditions: Metabolic Syndrome;   Diabetes
Intervention:
20 Completed Effect of Irvingia Gabonensis Administration on Metabolic Syndrome, Insulin Secretion and Insulin Sensitivity
Condition: Metabolic Syndrome X
Interventions: Dietary Supplement: Irvingia gabonensis;   Other: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.